Clik here to view.
Sanford Health Rare Disease Data Registry and C-Path’s RDCA-DAP Enter into a...
TUCSON, Ariz., October 16, 2024 – Critical Path Institute (C-Path) is pleased to announce the expansion of our partnership with the Coordination of Rare Diseases at Sanford Research (CoRDS). CoRDS...
View ArticleADHD Awareness Month: Addressing Disparities in Diagnosis and Treatment
October is ADHD Awareness Month, dedicated to raising awareness about Attention Deficit Hyperactivity Disorder (ADHD) and combating the stigma associated with it. According to the Centers for Disease...
View ArticleClik here to view.
Webinar: New Findings on Inequities in Rare Diseases: How They Impact...
Join us Tuesday, October 29, at noon Eastern for an important webinar, New Findings on Inequities in Rare Diseases: How They Impact Research and Clinical Trials Processes.” This session will be...
View ArticleClik here to view.
Webinar: Advanced in vitro modelling of neuromuscular diseases and therapeutics
Join us on November 14 at 12 p.m. eastern for a webinar that will explore innovative, multidisciplinary approaches in disease modeling, drug testing, and tissue engineering using advanced in vitro...
View ArticleClik here to view.
2025 Clinical Outcome Assessment Program Annual Meeting
Save the Date!2025 Clinical Outcome Assessment Program Annual Meeting On April 9-10, 2025, the 2025 Clinical Outcome Assessment Program Annual Meeting will be held at the Bethesda North Marriott &...
View ArticleThe Path to Accessibility: Installing ADA-Friendly Solutions
When C-Path launched its new website, it was built to be sleek, mobile, responsive and navigable. But there was one more key element: an integration that would install top-end solutions for those...
View ArticleClik here to view.
C-Path Announces Key Leadership Appointments in Neurodegenerative Disease...
Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD TUCSON, Ariz., November 7, 2024 — Critical Path Institute® (C-Path) today...
View ArticleC-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM‑PD)...
C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., November 13, 2024 — Critical Path Institute®...
View ArticleClik here to view.
C-Path’s Initiative to Optimize Clinical Trial Design in New-Onset Type 1...
In honor of World Diabetes Day and the need to improve diabetes treatment, Critical Path Institute’s Type 1 Diabetes Consortium (T1DC) would like to highlight its development of a regulatory grade...
View ArticleClik here to view.
Advancing Neonatal Drug Development: Celebrating Progress on World...
On this occasion of World Prematurity Awareness Day, we reflect on the immense progress we have made together and recognize the vital role you have played in advancing neonatal drug development. At...
View ArticleClik here to view.
C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type...
TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B....
View ArticleClik here to view.
Unlocking the Power of Data Sharing for LGMD Drug Development
Join us on December 12, 2024, at 11 a.m. ET for the webinar, “The Power of Data Sharing and Collaboration Across LGMDs in a Pre-Competitive, Neutral Environment.” This event will feature Dr. Volker...
View ArticleClik here to view.
C-Path’s Romero, Swingle Named to 100 Most Innovative and Influential...
C-Path CEO Klaus Romero and President & COO Kristen Swingle were recently named to the 100 Most Innovative and Influential Healthcare Leaders in AZ Big Media’s “Who’s Who in Healthcare for...
View ArticleA computational tool to optimize clinical trial parameter selection in...
Jordan Wilk, Varun Aggarwal, Mike Pauley, Diane Corey, Daniela J. Conrado, Karthik Lingineni, Juan Francisco Morales, Deok Yong Yoon, Yi Zhang, Zihan Cui, Jackson Burton, Jane Larkindale, Shu Chin Ma,...
View ArticleClik here to view.
Biomarkers 101: A Patient’s Perspective on the Importance of Identifying New...
Biomarkers are emerging as powerful tools in the field of kidney health, playing a crucial role in the diagnosis, monitoring, and treatment of kidney diseases. From the perspective of patients,...
View ArticleClik here to view.
Advanced in Vitro Modelling of Neuromuscular Diseases and Therapeutics
Join this webinar to explore innovative, multidisciplinary approaches in disease modeling, drug testing, and tissue engineering using advanced in vitro systems. Dr. Francesco Saverio Tedesco will...
View ArticleAutosomal Recessive Polycystic Kidney Disease (ARPKD)Adjunct EL-PFDD...
Executive SummaryThe mission of the Polycystic Kidney Disease (PKD) Foundation is to fund research, advocate for patients, and ultimately to end PKD. On August 29,2023, the PKD Foundation hosted the...
View ArticleVoice of the Patient report Externally-Led Patient-Focused Drug Development...
Authors and Collaborators:This report was prepared and submitted on behalf of the PKD Foundation by: Elise Hoover, Vice President of Research Programs, PKD Foundation; Sorin Fedeles, PhD, MBA,...
View ArticleThe Power of Data Sharing and Collaboration Across LGMDs in a...
This event featured Dr. Volker Straub, a renowned neuromuscular genetics expert and Director of the John Walton Muscular Dystrophy Research Centre at Newcastle University. Dr. Straub provided an...
View ArticleReal-world evidence in the cloud: Tutorial on developing an end-to-end data...
Wes Anderson, Roopal Bhatnagar, Keith Scollick, Marco Schito, Ramona Walls, Jagdeep T. PodichettyAbstractIn the rapidly evolving landscape of healthcare and drug development, the ability to efficiently...
View Article